*Corresponding Author:
C. H. Muralimohan
Department of Chemistry, School of Science, University of Management & Technology, Lahore-54770, Pakistan
E-mail: [email protected]
Date of Submission 25 April 2017
Date of Revision 08 November 2017
Date of Acceptance 06 June 2018
Indian J Pharm Sci 2018;80(4):776-780  

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms


Entomopathogenic fungus Beauveria bassiana widely used as biopesticide that specifically infect and kill insect pests. The present study was aimed to evaluate antioxidant and cytotoxic potentials of mycelia extracts of ten Beauveria bassiana isolates. Mycelia of Beauveria bassiana were extracted with hexane, ethyl acetate, methanol and water. Antioxidant activity possessed by the mycelial extracts was studied using the 1,1-diphenyl-2-picrylhydrazyl radical assay. Cytotoxic activity of mycelia extracts was tested using A-549 cell lines employing sulforhodamine B assay. Among all the mycelial extracts of Beauveria bassiana isolates, ethyl acetate extract exhibited highest antioxidant activity with an IC50 of 202.45 µg/ml. Highest cytotoxic activity was observed with the ethyl acetate extract (116 %) while standard cisplatin showed 102 %. Further investigations needed on isolation and characterization of secondary metabolites that could be responsible for these activities in a bid to develop new compounds for cancer.


Cytotoxic activity, antioxidant activity, Beauveria bassiana extracts, lung carcinoma cell line (A-549)

Natural products contain various compounds with antioxidants, antibacterial and cytotoxic properties [1]. Fungi are one of the groups of microorganisms, which are widely spread and having medicinal importance. Antioxidants are compounds that neutralize harmful free radicals and oxidants formed during metabolic reactions and help in prevention of cancer, cardiovascular diseases, neural disorders, Alzheimer’s disease, Parkinson’s disease, ulcerative colitis, alcohol-induced liver disease and other diseases [2]. Many antioxidant compounds are derived from natural sources including plants, fungi and bacteria [3]. Fungal metabolites are known for having antibacterial, antifungal, larvicidal, antioxidant and other activities [4-6]. Beauveria bassiana is one of the most used entomopathogenic fungi as an alternative to chemical pesticides in insect pest management [7]. B. bassiana has been used by Korean traditional healers to treat many diseases by consuming infected and dead insects [8]. B. bassiana produces exogenous metabolites like iso-isariin, felinones, destruxins, beauvericin are having antiviral, anticancer, antiinflammatory and antimalarial properties [9]. Insecticidal toxins produced by B. bassiana during process of infection in hemolymph of insects induces cytotoxicity [10]. Cytotoxic activity is one of the most focused areas for medicinal activities of secondary metabolites produced by bacteria, fungi, plants and animals. Acquiring resistance to chemotherapeutic drugs made focus on new metabolites to act against cancer cells [11]. Cytotoxic compounds are most promising compounds for curing cancers or tumours in a most systemic way. Isolation and characterization of metabolites with cytotoxic activities has demand for curing various diseases [12]. There have been very few reports on mycelial metabolites from B. bassiana with medicinal properties. The present investigation was taken up to study the antioxidant and cytotoxic properties of mycelial extract of ten B. bassiana isolates.

Ten B. bassiana isolates were used in the present study in which two isolates of B. bassiana (B. bassiana 1 and B. bassiana 2) were isolated from a local field infected insect Helicoverpa armigera on pigeon pea crop at Araku area of Visakhapatnam district and the remaining eight isolates (ARSEF 1166, ARSEF 3286, ARSEF 1512, ARSEF 1314, ARSEF 1149, ARSEF 1788, ARSEF 3120, ARSEF 326) were obtained from International Culture Collection Center USDA-Agricultural Research Service Collection of Entomopathogenic Fungi (ARSEF). B. bassiana isolates were cultured on modified Sabouraud’s dextrose broth fortified with 1 % yeast extract and incubated using shaking incubator at 100 rpm at 25° temperature for 10 d. After incubation, mycelia were separated using two fold muslin cloths under aseptic conditions and rinsed with sterilized double-distilled water. Mycelia were dried in hot air oven at 45° for 48 h and packed in sterile polypropylene bags in aseptic conditions [13].

Dried mycelia was homogenized using motor and pestle under sterile conditions and 10 g of mycelia powder was extracted with 100 ml of solvents hexane, ethyl acetate, methanol and water (AR grade, purchased from S. D. Fine-Chem Limited) for 24 h using Soxhlet extraction apparatus (Borosil). The crude extracts were concentrated at 40° using rotary evaporator apparatus (Buchi r-300) and preserved in deep freezer (Blue Star Ltd.) at –20° until further use [14].

Radical scavenging activity for the B. bassiana mycelia extracts was studied using 2,2diphenyl- 1-picrylhydrazyl (DPPH) purchased from Sigma- Aldrich. DPPH solution was prepared in methanol (4 mg/100 ml) and placed in the dark for overnight for release of free radicals. Three millilitres of DPPH solution was mixed with mycelial extracts of concentrations 10, 25, 50, 100, 250, 500, 750 and 1000 μg/ml and incubated for 20 min at 37° in a water bath and the decrease in absorbance was recorded at 515 nm was measured using spectrophotometer (Elico) against blank containing methanol in DPPH solution. The experiment was repeated for three times. Radical scavenging activity was calculated using the following Eqn. [15], percent inhibition = [(AB–AE)/AB]×100, where, AB is the absorbance of blank sample and AE is the absorbance of extract. Scavenging activity against the concentration of mycelia extracts was plotted and IC50 was determined.

Human lung carcinoma cell line (A-549) was obtained from NCIM, Pune and maintained on RPMI-1640 medium supplemented with 10 % fetal bovine serum amended with 10 U penicillin, 100 U streptomycin and incubated at 37°, 5 % CO2 was provided using CO2 incubator (Thermo Scientific) [16]. The cytotoxicity of the extracts was determined by testing on A-549 cell line. Colorimetric assay using sulforhodamine B (SRB) reaction was used for a quantitative measurement of cell growth and viability [17]. Cells (190 μl, 5×103 cells per well) were added in 96-well microtiter plates and were grown in a drug free medium for 18 h. Mycelium extracts (1 μg/μl) were added in aliquots of 10 μl (dissolved in DMSO/H2O, 1:9) and incubated for 48 h in CO2 incubator under 5 % CO2 and the cytotoxicity was measured by SRB methodology: cells were fixed by adding 50 μl of cold 50 % (w/v) trichloroacetic acid and incubated for 60 min at 4°. Plates were washed with deionized water and dried, 100 μl of SRB solution (0.4 % w/v SRB in 1 % acetic acid) was added to each microtiter well and incubated for 10 min at room temperature. Unbound SRB was removed by washing with 1 % acetic acid and plates were air dried. Add 100 μl of Tris buffer to dissolve bound strain. Optical densities were read on an automated spectrophotometric plate reader (Biorad) at a single wavelength of 560 nm. The activity of the mycelia extracts was given in percent growth inhibition (GI) for concentration tested (0.050 μg/μl) [18]. The experiment was repeated three times.

GI was calculated by using formula, % GI = 100–cell growth and percent cell growth-based was calculated on OD obtained at 560 nm with compare to the untreated cells. Negative % GI- no GI (not active); <50 % GIweak GI (not active); 50 to 100 % GI- moderate to high GI (active, GI effect); 100 % GI- total GI (active, cytostatic effect); >100 % GI- cell killing (active, cytotoxic effect).

Among the 10 isolates of B. bassiana mycelial extracts in water, methanol, ethyl acetate and hexane tested for antioxidant activity, ethyl acetate extracts of B. bassiana exhibited highest antioxidant activity (% inhibition) of free radicals at 1000 μg/ml (Figure 1) and IC50 values (Figure 2). The order of antioxidant activity exhibited by the ethyl acetate extracts of ten B. bassiana isolates was B. bassiana 2 (95.59 %) followed by B. bassiana 1 (94 %)>ARSEF 1788 (79.41 %)>ARSEF 326 (72.86 %)>ARSEF 3120 (69.57 %)>ARSEF 1149 (66.18 %)>ARSEF 1314 (64.86 %)>ARSEF 1512 (62.32 %)>ARSEF 3286 (60.87 %)>ARSEF 1166 (54.93 %), Figure 1. Abourashed [19] reported that the 8-hydroxysilybin (194.67 μg/ml), 7-O-b-D-4-Omethylglucopyranoside (0.4667 μg/ml), herbacetin 8-O-b-D-glucopyranoside (1.7 μg/ml; metabolites produced from B. bassiana) displayed antioxidant activity with good percent inhibition of free radicals. Study on 42 entomopathogenic fungi includes isolates of Beauveria, Metarhizium and Paecilomyces were having significant antioxidant activities with highest activity reported from B. bassiana [20]. Polysaccharides produced by the medicinal entomopathogenic fungi Cordyceps militaris have significant antioxidant and antitumor activities [21]. Antioxidant enzymes were very important in overcoming insect ROS produced during infection and genetic analysis exposed many genes related to the enzymes and metabolites with antioxidant activity [22].


Figure 1: Inhibition of DPPH radical by extracts of 10 B. bassiana isolates
Percent inhibition of DPPH radicals by water, methanol, ethyl acetate and hexane extracts of 10 B. bassiana isolates. The results are mean ± SE of three replicates


Figure 2: IC50 values of extracts of 10 B. bassiana isolates
IC50 values of water, methanol, ethyl acetate and hexane extracts of 10 B. bassiana isolates. The results are mean ± S E of three replicates

Among the extracts of ten B. bassiana isolates, ethyl acetate extract of B. bassiana showed highest cytotoxic activity of 116.16 % GI, more than 100 % GI activity on A-549 lung carcinoma cell lines followed by B. bassiana 1 (95 %)>ARSEF 1788 (88.45 %)>ARSEF 1166 (85.71 %)>ARSEF 1512 (81.39 %)>ARSEF 1314 (80.31 %)>ARSEF 326 (75.57 %)>ARSEF 3286 (73.34 %)>ARSEF 3120 (71.59 %) and low in ARSEF 1149 (67.27 %) showed cytotoxic activity in range of 50-100 %. B. bassiana mycelium water, methanol and hexane extracts showed GI activity below 50 % indicating low or no activity (Figure 3). Cytotoxic activity was observed by ethyl acetate extracts of Cordyceps sinensis with ED50 less than 25 μg/ml and induced apoptosis through DNA fragmentation, chromatin condensation and proteolysis of ribose polymerase [23]. Cytotoxic activity by Hirsutella sp. entomopathogenic fungi by using Chinese hamster ovary cells reported highest activity with 98 % in ethyl acetate and methyl chloride extracts at 100 μg/ml concentration. Potential cytotoxic activity of Beauveria feline was tested against HL-60 (leukaemia), B16 (melanoma) and HCT8 (colon) cancer cell lines with significant cytotoxic activity. Antioxidant and cytotoxic activity exhibited by mycelia extracts of tested B. bassiana strains extracted with ethyl acetate as solvent can help in discovery of metabolites that are medicinally useful. Further work need to be carried out to isolate potential compound from B. bassiana mycelia extract. Present study infers that there are active and potential antioxidants and cytotoxic activity compounds in entomopathogenic fungus Beauveria sp. and further research can develop a potential drug for antioxidant and cytotoxicity.


Figure 3: Cytotoxic activity of extracts of 10 B. bassiana isolates on A-549 Cell lines
Cytotoxic activity of water, methanol, ethyl acetate and hexane extracts of 10 B. bassiana isolates on lung carcinoma (A-549). The results are mean ± SE of three replicates


The authors thank Dr. Richard Humber, Insect Mycologist and Curator, ARSEF Collection of Entomopathogenic Fungal Cultures, Ithaca, USA for providing cultures. The authors also thank the help provided by the Management of GITAM (Deemed to be University) and Department of Biotechnology, GIT, GITAM University for allowing the use of their facilities to carry out the work.

Conflict of interest

The authors declare no conflicts of interest.